| |
|
|
 |
|
print
|
 |
|
|
 |
Advantages of Potelligent® CHOK1SV — The Potelligent® CHOK1SV cell line retains the desirable features of a high-productivity cell line (robust, high-yielding, scalable) — Proven bioprocess platform for CHOK1SV is repeatable in the new cell line — Antibodies produced by the new cell line: * Can exert potent cytotoxic effects even when their target antigen density is low * Retain all the other desirable features of antibodies such as Protein A binding
|
The fucose-free antibodies produced by Potelligent® CHOK1SV show enhanced ADCC level compared to parental CHOK1SV cell line. Potelligent® CHOK1SV is already in use with Lonza customers for development of therapeutic antibodies. The high productivity and enhanced antibody potency are expected to contribute to a signifi cant reduction in the cost of goods for an antibody-based drug. |
|
|
|
|
|
|
|
|
 |